FG
EHC icon

Formula Growth’s Encompass Health EHC Stock Holding History

Formula Growth’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
10,340
-63
-0.6% -$6.53K 0.37% 102
2026
Q1 		$1.01M Sell
10,403
-5,031
-33% -$516K 0.45% 81
2025
Q4 		$1.64M Sell
15,434
-11,266
-42% -$1.31M 0.63% 61
2025
Q3 		$3.39M Buy
+26,700
New +$3.18M 1.21% 28

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Formula Growth's EHC Position: Q2 2026 in Review

Formula Growth reduced its Encompass Health (EHC) stake by 0.61% in Q2 2026, selling an estimated $6.53K and leaving 10,340 shares worth $1.05M. The position accounts for 0.37% of the portfolio, ranked #102.

Formula Growth first reported a position in EHC in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.39M in Q3 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Formula Growth held 10,340 shares of Encompass Health worth $1.05M as of Q2 2026.
  • Formula Growth sold 63 Encompass Health shares in Q2 2026, an estimated $6.53K.
  • Encompass Health made up 0.37% of Formula Growth's portfolio in Q2 2026, its #102 holding.
  • Formula Growth first reported a position in Encompass Health in Q3 2025 and has held it in 4 quarters since.
  • Formula Growth's Encompass Health position peaked at $3.39M in Q3 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.